Detalhe da pesquisa
1.
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial.
Lancet
; 402(10404): 798-808, 2023 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37451295
2.
Immune checkpoint inhibition and targeted therapy for melanoma: A patient-oriented cross-sectional comparative multicentre study.
J Eur Acad Dermatol Venereol
; 37(5): 884-893, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36433671
3.
Immunogenicity of COVID-19 Vaccination in Melanoma Patients under Immune Checkpoint Blockade.
Oncology
; 100(7): 392-398, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35609553
4.
Mogamulizumab als Auslöser einer Psoriasis vulgaris bei einem Patienten mit Mycosis fungoides.
J Dtsch Dermatol Ges
; 19(9): 1355-1358, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34541802
5.
Psoriasis vulgaris triggered by treatment with mogamulizumab in a patient with cutaneous T-cell lymphoma.
J Dtsch Dermatol Ges
; 19(9): 1355-1358, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34357675
6.
[Social participation and melanoma during the COVID-19 pandemic]. / Soziale Teilhabe und Hautkrebs während der COVID-19-Pandemie.
Dermatologie (Heidelb)
; 74(2): 108-113, 2023 Feb.
Artigo
em Alemão
| MEDLINE | ID: mdl-36645432
7.
Monocyte chemoattractant protein 1 as a potential biomarker for immune checkpoint inhibitor-associated neurotoxicity.
Cancer Med
; 12(8): 9373-9383, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36794673
8.
Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG.
J Immunother Cancer
; 11(4)2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37028819
9.
Reinduction of Hedgehog Inhibitors after Checkpoint Inhibition in Advanced Basal Cell Carcinoma: A Series of 12 Patients.
Cancers (Basel)
; 14(21)2022 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36358887
10.
MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma - An evaluation of the multicenter prospective skin cancer registry ADOREG.
Eur J Cancer
; 167: 32-41, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35366571
11.
Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany.
Cancers (Basel)
; 14(7)2022 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35406577
12.
Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG.
J Immunother Cancer
; 10(6)2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35688555
13.
Sirolimus diminishes the expression of GRO-α (CXCL-1) /CXCR2 axis in human keratinocytes and cutaneous squamous cell carcinoma cells.
J Dermatol Sci
; 104(1): 30-38, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34479772
14.
Case Report: Sustained Remission Due to PD-1-Inhibition in a Metastatic Melanoma Patient With Depleted B Cells.
Front Immunol
; 12: 733961, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34675925
15.
Lipase elevation and type 1 diabetes mellitus related to immune checkpoint inhibitor therapy - A multicentre study of 90 patients from the German Dermatooncology Group.
Eur J Cancer
; 149: 1-10, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33812141